Zurcher Kantonalbank (Zurich Cantonalbank) Mersana Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	BUY	$3.08 - $9.55 $16,052 - $49,774	5,212 Added 42.56%	17,459 $57,000
Q4 2022 Feb 01, 2023	BUY	$5.65 - $7.86 $28,165 - $39,182	4,985 Added 68.65%	12,247 $71,000
Q1 2022 Apr 21, 2022	SELL	$3.74 - $6.63 $9,589 - $16,999	-2,564 Reduced 26.09%	7,262 $29,000
Q4 2021 Feb 01, 2022	SELL	$5.48 - $9.86 $1,457 - $2,622	-266 Reduced 2.64%	9,826 $61,000
Q3 2021 Nov 15, 2021	BUY	$8.56 - $14.47 $94 - $159	11 Added 0.11%	10,092 $95,000
Q2 2021 Jul 30, 2021	BUY	$13.28 - $18.07 $1,779 - $2,421	134 Added 1.35%	10,081 $137,000
Q1 2021 May 03, 2021	BUY	$15.31 - $26.52 $41,107 - $71,206	2,685 Added 36.97%	9,947 $161,000
Q4 2020 Jan 28, 2021	BUY	$16.84 - $27.59 $26,741 - $43,812	1,588 Added 27.99%	7,262 $193,000
Q2 2020 Jul 28, 2020	BUY	$5.24 - $23.4 $29,731 - $132,771	5,674 New	5,674 $133,000

Others Institutions Holding MRSN

# of Institutions

125

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

Eco R1 Capital, LLC San Francisco, CA

19.4M
Shares

$11.8 Million
1.59% of portfolio
Nextech Invest Ag

12.1M
Shares

$7.36 Million
3.72% of portfolio
Vr Adviser, LLC New York, NY

11.3M
Shares

$6.91 Million
2.22% of portfolio
Bain Capital Life Sciences Investors, LLC Boston, MA

8.66M
Shares

$5.28 Million
2.94% of portfolio
Black Rock Inc. New York, NY

8.38M
Shares

$5.11 Million
0.0% of portfolio

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $59.3M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account